These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24256264)

  • 1. Monitoring mitochondrial dynamics and complex I dysfunction in neurons: implications for Parkinson's disease.
    Simcox EM; Reeve A; Turnbull D
    Biochem Soc Trans; 2013 Dec; 41(6):1618-24. PubMed ID: 24256264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
    Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
    Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.
    Van Laar VS; Berman SB
    Neurobiol Dis; 2013 Mar; 51():43-55. PubMed ID: 22668779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.
    Devi L; Raghavendran V; Prabhu BM; Avadhani NG; Anandatheerthavarada HK
    J Biol Chem; 2008 Apr; 283(14):9089-100. PubMed ID: 18245082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dynamics in Parkinson's disease.
    Van Laar VS; Berman SB
    Exp Neurol; 2009 Aug; 218(2):247-56. PubMed ID: 19332061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for Compartmentalized Axonal Mitochondrial Biogenesis: Mitochondrial DNA Replication Increases in Distal Axons As an Early Response to Parkinson's Disease-Relevant Stress.
    Van Laar VS; Arnold B; Howlett EH; Calderon MJ; St Croix CM; Greenamyre JT; Sanders LH; Berman SB
    J Neurosci; 2018 Aug; 38(34):7505-7515. PubMed ID: 30030401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial control of cell bioenergetics in Parkinson's disease.
    Requejo-Aguilar R; Bolaños JP
    Free Radic Biol Med; 2016 Nov; 100():123-137. PubMed ID: 27091692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
    Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model.
    Arnold B; Cassady SJ; VanLaar VS; Berman SB
    Neurobiol Dis; 2011 Jan; 41(1):189-200. PubMed ID: 20850532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in Parkinson's disease.
    Bose A; Beal MF
    J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson's disease.
    Franco-Iborra S; Cuadros T; Parent A; Romero-Gimenez J; Vila M; Perier C
    Cell Death Dis; 2018 Nov; 9(11):1122. PubMed ID: 30405116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction and oxidative stress in Parkinson's disease.
    Subramaniam SR; Chesselet MF
    Prog Neurobiol; 2013; 106-107():17-32. PubMed ID: 23643800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.
    Exner N; Lutz AK; Haass C; Winklhofer KF
    EMBO J; 2012 Jun; 31(14):3038-62. PubMed ID: 22735187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of electron transport as potential novel therapy in Parkinson's disease with mitochondrial dysfunction.
    Vos M; Verstreken P; Klein C
    Biochem Soc Trans; 2015 Apr; 43(2):275-9. PubMed ID: 25849929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial respiratory chain disorganization in Parkinson's disease-relevant PINK1 and DJ1 mutants.
    Lopez-Fabuel I; Martin-Martin L; Resch-Beusher M; Azkona G; Sanchez-Pernaute R; Bolaños JP
    Neurochem Int; 2017 Oct; 109():101-105. PubMed ID: 28408307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Complex I Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease.
    Milanese C; Tapias V; Gabriels S; Cerri S; Levandis G; Blandini F; Tresini M; Shiva S; Greenamyre JT; Gladwin MT; Mastroberardino PG
    Antioxid Redox Signal; 2018 Jan; 28(1):44-61. PubMed ID: 28816057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
    Chinta SJ; Andersen JK
    Free Radic Biol Med; 2006 Nov; 41(9):1442-8. PubMed ID: 17023271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.
    Hastings TG
    J Bioenerg Biomembr; 2009 Dec; 41(6):469-72. PubMed ID: 19967436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.